University Hospital Southampton

Southampton So166yd

6 studies enrolling now · 28 studies all time

What they study most

Acute Coronary Syndrome, Advanced Solid Tumors, Alzheimer Disease, Asthma, Atherosclerosis of Extremities, Cholangiocarcinoma, Chronic Cough, Cystic Fibrosis, Cystic Fibrosis - Complete, Diffuse Large B-cell Lymphoma, Dry Age-related Macular Degeneration, Enterocutaneous Fistula

Studies at this site

• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk — Recruiting now
• A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF — Recruiting now
• The Dragon PLC Trial (DRAGON-PLC) — Recruiting now
• Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort — Recruiting now
• A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
• Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow — Running, not enrolling
• On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study — Running, not enrolling
• A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
• A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines — Completed
• Chyme Reinfusion for Type 2 Intestinal Failure — Completed
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — Running, not enrolling
• Study to Evaluate CCS1477 in Advanced Tumours — Completed
• Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study — Running, not enrolling
• Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) — Running, not enrolling
• Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer — Running, not enrolling
• Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation — Completed
• A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate — Completed
• Approaches and Decisions for Acute Pediatric TBI Trial — Completed
• A Factor IX Gene Therapy Study (FIX-GT) — Stopped early
• Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — Running, not enrolling
• GB001 in Adult Subjects With Moderate to Severe Asthma — Completed
• A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF — Stopped early
• Study Designed to Assess the Safety, Tolerability and PK of PTI-808 in Healthy Volunteers and in Adults With Cystic Fibrosis — Completed
• EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients — Completed
• Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer — Completed
• A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI — Completed